Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy (Q39591605)
Jump to navigation
Jump to search
scientific article published on 15 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy |
scientific article published on 15 July 2016 |
Statements
1 reference
Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy (English)
1 reference
Porntipa Korprasertthaworn
15 July 2016
1 reference